MedTrace Logo

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

NCT07148999 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-09-29

No results posted yet for this study

Summary

A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.

Conditions

  • Infertility (IVF Patients)

Interventions

COMBINATION_PRODUCT

Opt-IVF

Opt-IVF provides optimized dosage profile for each patient

OTHER

Control

Physicians will decide the dosage for each day for patients

Sponsors & Collaborators

  • IVF Academy of USA

    collaborator UNKNOWN

  • Positivf Fertility

    collaborator UNKNOWN

  • Urmila DIwekar

    lead INDUSTRY

Principal Investigators

  • Paul Magarelli, M.D., Ph.D. · IVF Academy USA

  • Francesco Arredondo, MD, Ph.D. · Positivf Fertility

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-23
Primary Completion
2026-02-15
Completion
2026-02-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07148999 on ClinicalTrials.gov